PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Genamics JournalSeek
- SafetyLit
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Tomas Fazekas
Tomas Fazekas
Slovakia
Publications
-
Research Article
Is Screening of Hepatocellular Carcinoma in Patients Without Cirrhosis Reasonable?
Author(s): Viera Kissova, Gabriel Hajas, Adrian Kiss, Tomas Fazekas, Zuzana Straussova, Jaroslav Rosenberger and Maria MajernikovaViera Kissova, Gabriel Hajas, Adrian Kiss, Tomas Fazekas, Zuzana Straussova, Jaroslav Rosenberger and Maria Majernikova
Occurrence of hepatocellular carcinoma (HCC) in a non-cirrhotic condition of liver disease is now already well known. Non-cirrhotic condition was defined in our study as the presence of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH). The rising onset of obesity, metabolic syndrome (MS) and Type 2 Diabetes Mellitus (T2DM) is associated with NAFLD or NASH. Currently only cirrhotic patients are required to be regularly (semi-annually) screened for liver neoplasma. The goal of this study was to describe the onset of HCC in patients admitted to an Internal Ward due to nonspecific symptoms of neoplasma and to identify a specific group of patients that could benefit from screening of hepatocellular carcinoma so that the disease is diagnosed in its early stages with promising prospects for successful treatment. .. View More»
DOI: 10.4172/2167-7182.1000436